-
Synthesis of naphtho{2,3-c}pyrans including the aphin-derived quinone A'
-
Syntheses related to some naturally occurring naphthopyranquinones
-
Novel macrocycles: from synthesis to supramolecular function
-
Syntheses of novel acyclic amino-amido ligands
-
Synthesis of some novel 4-arylidene pyrazoles as potential antimicrobial agents
-
Synthesis and structural elucidation of a novel bis-spirooxindole from isatin and ethylenediamine
-
Semisynthesis, characterisation, and antibacterial evaluation of a novel lecanoric acid-derived amide library
-
Synthesis of novel 1,2,4-oxadiazole-isoxazoline hybrids and their in silico potential with adenosine receptors
-
Synthesis of side-chain-modified mycothiol analogues incorporating carbazole quinones, and evaluation as inhibitors of enzymes in the Mycobacteria
-
Rh(III)-catalyzed chelation-assisted C–H activation/annulation of 2-arylimidazolines with cyclic diazo-1,3-dicarbonyl compounds: a novel approach to tetracyclic annulated derivatives of 2,3-dihydroimidazo[2,1-a]isoquinoline
-
Syntheses of luciferins and their bioluminescent evaluation
-
Recent advances in the discovery and design of multicomponent reactions for the generation of small-molecule libraries
-
Regulation of protein–protein interactions using stapled peptides
-
Stereoselective total synthesis of lippialactone
-
Synthesis and characterization of multi-allyl-functionalized polylactic acid and polyhydroxybutyrate polyurethane, and their cross-linking by copolymerization with 2-hydroxylethyl methacrylate
-
Recent advances in green fluorine chemistry
-
C-H amination in the synthesis of N-heterocycles
-
Back2Basics: interpreting chromatograms in LC-MS based proteomics
-
Back2Basics: interpreting chromatograms in LC-MS based proteomics
-
ASH: a new protein domain on the horizon
-
ASH: a new protein domain on the horizon
-
Identification of differentially expressed genes and drug targets in prostate cancer using next-generation sequencing analysis and docking
-
Identification of differentially expressed genes and drug targets in prostate cancer using next-generation sequencing analysis and docking
-
Cysteine: bridging obesity, cancer, and anti-microbial resistance
